Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

被引:647
作者
Zhao, Chen
Irie, Naoko
Takada, Yasunari
Shimoda, Kouji
Miyamoto, Takeshi
Nishiwaki, Toru
Suda, Toshio
Matsuo, Koichi [1 ]
机构
[1] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Lab Anim Ctr, Shinjuku Ku, Tokyo 1608582, Japan
[3] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Shinjuku Ku, Tokyo 1608582, Japan
[4] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan
关键词
D O I
10.1016/j.cmet.2006.05.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bone homeostasis requires a delicate balance between the activities of bone-resorbing osteoclasts and bone-forming osteoblasts. Various molecules coordinate osteoclast function with that of osteoblasts; however, molecules that mediate osteoclast-osteoblast interactions by simultaneous signal transduction in both cell types have not yet been identified. Here we show that osteoclasts express the NFATc1 target gene Efnb2 (encoding ephrinB2), while osteoblasts express the receptor EphB4, along with other ephrin-Eph family members. Using gain- and loss-of-function experiments, we demonstrate that reverse signaling through ephrinB2 into osteoclast precursors suppresses osteoclast differentiation by inhibiting the osteoclastogenic c-Fos-NFATc1 cascade. In addition, forward signaling through EphB4 into osteoblasts enhances osteogenic differentiation, and overexpression of EphB4 in osteoblasts increases bone mass in transgenic mice. These data demonstrate that ephrin-Eph bidirectional signaling links two major molecular mechanisms for cell differentiation - one in osteoclasts and the other in osteoblasts - thereby maintaining bone homeostasis.
引用
收藏
页码:111 / 121
页数:11
相关论文
共 56 条
[41]   EPH receptor signalling casts a wide net on cell behaviour [J].
Pasquale, EB .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (06) :462-475
[42]   MODULATION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR ACTIVITY IN BONE CULTURES BY OSTEOTROPIC HORMONES [J].
PFEILSCHIFTER, J ;
MUNDY, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (07) :2024-2028
[43]   c-Fos suppresses systemic inflammatory response to endotoxin [J].
Ray, N ;
Kuwahara, M ;
Takada, Y ;
Maruyama, K ;
Kawaguchi, T ;
Tsubone, H ;
Ishikawa, H ;
Matsuo, K .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (05) :671-677
[44]  
Sharfe N, 2002, EUR J IMMUNOL, V32, P3745, DOI 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO
[45]  
2-M
[46]   A phage display technique identifies a novel regulator of cell differentiation [J].
Sheu, TJ ;
Schwarz, EM ;
Martinez, DA ;
O'Keefe, RJ ;
Rosier, RN ;
Zuscik, MJ ;
Puzas, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :438-443
[47]   Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway [J].
Steinle, JJ ;
Meininger, CJ ;
Forough, R ;
Wu, G ;
Wu, MH ;
Granger, HJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :43830-43835
[48]  
Takasu Junichiro, 2002, BMC Blood Disord, V2, P3, DOI 10.1186/1471-2326-2-3
[49]   RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β [J].
Takayanagi, H ;
Kim, S ;
Matsuo, K ;
Suzuki, H ;
Suzuki, T ;
Sato, K ;
Yokochi, T ;
Oda, H ;
Nakamura, K ;
Ida, N ;
Wagner, EF ;
Taniguchi, T .
NATURE, 2002, 416 (6882) :744-749
[50]   Genetic regulation of osteoclast development and function [J].
Teitelbaum, SL ;
Ross, FP .
NATURE REVIEWS GENETICS, 2003, 4 (08) :638-649